Ultima-CJC1295 DAC 2mg

MANUFACTURER
Ultima Pharmaceuticals - USA
WAREHOUSE
USA Warehouse 5
SUBSTANCE
GHRH Peptide

For security reasons, products are shipped without brand labels.

Introducing CJC-1295, a cutting-edge synthetic analogue of growth hormone-releasing hormone (GHRH) crafted from 30 amino acids. This remarkable peptide has demonstrated its efficiency in stimulating the release of growth hormone and IGF-1, all while preserving the natural pulsatile rhythm of GH secretion.

CJC-1295 is often combined with Ipamorelin, enhancing its specificity as a GHRH. Unlike many peptides in its class, CJC-1295 encourages growth hormone release without the unwanted side effects of increased appetite, cortisol, acetylcholine, prolactin, or aldosterone. Well-tolerated and effective, it works synergistically with Ipamorelin for optimal results.

Target Gland: Pituitary

• Boosted growth hormone and IGF-1 levels without elevating prolactin
• Increased body weight and length through enhanced protein synthesis
• Significant muscle growth
• Improved bone density
• Strengthened immune function
• Enhanced cognition and memory
• Increased collagen production for healthier skin
• Effective fat reduction
• Promoted cellular repair and regeneration

Notably, CJC-1295 also facilitates slow-wave deep sleep, essential for optimal muscle growth, memory retention, and overall rejuvenation.

Two Forms of CJC-1295:

GHRH is produced in the hypothalamus, triggering a pulsatile release of GH from the pituitary gland. However, GHRH has a very short half-life of just a few minutes. The active segment of GHRH comprises the first 29 amino acids, which can be synthesized as a peptide called Sermorelin. Sermorelin extends its half-life to 30 minutes, leading to CJC-1295. Further modification, known as CJC-1295 + DAC, allows it to bind with blood protein albumin, extending its half-life to 8 days. There is also a non-DAC version of CJC-1295 that simulates a more natural GH spike each night.

Thanks to its extended half-life with DAC, injections are required only once or twice a week. However, this steady blood level may provide a continuous stimulus for GH release through the GHRH receptor, which might not replicate natural physiological conditions. Consequently, this could reduce the amplitude of the GH pulse and its tissue-stimulating effects.

Safety Considerations:

To promote optimal pituitary function, it is recommended to take "hormone holidays" every three to six months for three months. During these breaks, Sermorelin can serve as an effective alternative to CJC-1295 + DAC. These breaks may also help mitigate the risk of developing GH resistance, potentially caused by antibodies that deactivate GH or a decrease in GH receptor numbers through down-regulation. While these concerns remain theoretical due to the absence of long-term studies, they warrant attention.

Possible side effects of CJC-1295 might include localized reactions at the injection site (such as irritation, redness, swelling, pain, and itching), headaches, diarrhea, vasodilation (flushing, warmth, temporary drops in blood pressure), nausea, and abdominal discomfort.